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a b s t r a c t
Actinomycete strainSA198, isolated fromaSaharan soil sampleofAlgeria, exhibitedantimicrobial activity
against Gram-positive and Gram-negative bacteria, and phytopathogenic and toxinogenic fungi. The
morphological and chemotaxonomic characteristics of the strainwere consistent with those of the genus
Saccharothrix. Analysis of the 16S rRNA gene sequence of strain SA198 showed a similarity level ranging
between 97.2 and 98.8% within Saccharothrix species, S. australiensis being the most closely related. Two
new active products were isolated by reverse HPLC using a C18 column. The ultraviolet–visible (UV–VIS),
infrared (IR),mass, and 1Hand 14Cnuclearmagnetic resonance (NMR) spectra showed that theseproducts
were new bioactive compounds. The minimum inhibitory concentrations of these antibiotics showed a
strong activity against fungi andmoderate activities against Gram-positive and Gram-negative bacteria.
1. Introduction
As a result of the increasing prevalence of antibiotic resistant
pathogens and the high incidence of fungal infections, the search
for novel antibiotics has becomemore urgent. Amongmicroorgan-
isms, actinomycetes continue to be one of the groups the most
investigated by screening for new bioactive molecules. Of all the
antibiotics used in practice, more than 90% originate from acti-
nomycetes, which produce about two-thirds of all the bioactive
substances of microbial origin discovered (Berdy 2005).
In recent years, the rate of discovery of new antibiotics has
decreased in the genus Streptomyces, from which a large number
of antibiotics was obtained and studied in the past. Therefore, the
search for novel compounds can also be concentrated on the iso-
lation of non-Streptomyces actinomycetes. The rare actinomycetes
thus constitute one of the most attractive sources of new bioactive
metabolites and become crucial microorganisms in this context.
The relevance of the non-Streptomyces actinomycetes in this regard
can also be demonstrated by the fact that they also produce
many interesting antibiotics, such as Micromonospora, Nocardia,
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Nocardiopsis, Saccharothrix, Actinomadura, Actinoplanes, Amyco-
latopsis, Saccharopolyspora and Streptosporangium (Genilloud et al.
2011). Selective isolation methods have therefore been developed
for taxa that are rarely isolated by conventional dilution plate
methods (Hayakawa et al. 1995; Sabaou et al. 1998). The develop-
ment andmassive application of genus-oriented selective isolation
methods,mainly appliedby industrial researchers, has given signif-
icant impetus to thediscoveryofnewmicrobial products ofmedical
importance (Lazzarini et al. 2001). On the other hand, the explo-
ration of new soils and habitats has been remarkably successful,
and several rare actinomycetes have been noted as new sources of
antibiotics (Sanglier et al. 1996; Lamari et al. 2002; Zitouni et al.
2004a; Bull and Stach 2007).
The Saharan soils of Algeria, exposed to an arid climate, con-
tain an abundance of actinomycetes, and several rare genera have
been detected. The presence of Saccharothrix genuswas signaled on
manysamplesof these soils (Sabaouetal. 1998;Zitouni et al. 2004b;
Zitouni et al. 2005). It has also been found that Saccharothrix strains
of these soils produce new antibiotics, such as dithiolopyrrolones
(Lamari et al. 2002; Merrouche et al. 2011) and anthracyclines
(Zitouni et al. 2004a). These promising results emphasize the need
to continue the research in this direction.
In the present work, we describe the isolation, from a Saha-
ran soil sample, of a Saccharothrix strain designated SA198, and its
identification by conventional andmolecularmethods, and also the
production, isolation and characterization of the new antibiotics it
provides.
2. Methods
2.1. Strain isolation
The actinomycete strain SA198 was isolated from a Saharan
soil sample collected at Tamanrasset in southern Algeria (lati-
tude 22◦49′07′′N, longitude 5◦25′56′′E, altitude 1370m). The dry
soil sample was suspended in sterile distilled water and diluted.
Aliquots (0.2ml) of each dilution were spread on the surface of
chitin–vitamins agar (Hayakawa and Nonomura 1987) supple-
mented with actidione (50mgml−1). The plates were incubated at
30 ◦C for 2 weeks.
2.2. Taxonomic studies
2.2.1. Morphological and cultural characteristics
The morphological and cultural characteristics were investi-
gated on various ISP media from the International Streptomyces
Project (ISP) (Shirling and Gottlieb 1966): yeast extract–malt
extract agar (ISP2), oatmeal agar (ISP3), inorganic salts starch
agar (ISP4), tryptic soy agar (TSA), nutrient agar and Bennett agar
(Waksman 1961). The degree of growth, aerial mycelia, pigmenta-
tion and other features were recorded after 7, 14 and 21 days of
incubation at 30 ◦C from naked eye examinations. Micromorpho-
logical observationsweremadewith light andelectronmicroscopy.
The colors of substrate and aerialmycelia and any soluble pigments
produced were determined according to the ISCC-NBS centroid
color charts (Kelly and Judd 1976).
2.2.2. Chemotaxonomic analysis
Biomass for chemotaxonomic analysis was obtained from cul-
ture grown in shake ISP2 medium (Shirling and Gottlieb 1966)
and incubated at 30 ◦C for 5 days. Cells of SA198 strain were har-
vested by centrifugation, washed in distilled water and hydrolyzed
for diaminopimelic acid isomers (Becker et al. 1964), whole-cell
sugar pattern (Lechevalier and Lechevalier 1970) and phospho-
lipids (Minnikin et al. 1977) analysis.
2.2.3. Physiological characteristics
Themedia andprocedures used for thedeterminationof physio-
logical features and carbon source utilizationwere those described
by Locci (1989). Strain SA198 was examined for its ability to uti-
lize three amino acids as sole nitrogen sources (alanine, proline
and serine), and 22 carbohydrate compounds and nine organic
acids as sole carbon sources. Degradation activities of strain SA198
were observed on variousmedia containing 12 organic compounds
(adenine, arbutin casein, esculin, gelatine guanine, hypoxanthine,
starch, testosterone, tyrosine, Tween 80 and xanthine). Melanoid
pigment production was tested on peptone yeast extract-iron agar
(ISP6) and tyrosine agar (ISP7) media (Shirling and Gottlieb 1966).
The production of nitrate reductase and the growth at different
temperatures (37 ◦Cand45 ◦C) andpH (5.0 and9.0), and in thepres-
ence of chloramphenicol (30mgml−1), erythromycin (15mgml−1)
and novobiocin (5mgml−1), were also studied.
2.2.4. DNA preparation, PCR amplification and sequence analysis
DNA was extracted using the procedure recommended
by Liu et al. (2000). PCR amplification of the 16S rRNA
gene sequence of strain SA198 was performed using two
primers: 27f (5′-AGAGTTTGATCCTGGCTCAG-3′) and 1492r (5′-
GGTTACCTTGTTACGACTT-3′). The 16S rRNA gene sequence was
amplified by PCR using an Invitrogen Kit. The final 50ml volume
of reaction mixture contained 1X PCR buffer (10mM of Tris–HCl,
50mM of KCl, pH 9.0 at 25 ◦C), 1.5mM of MgCl2, 200mM of each
dNTP, 1mM of each primer, 1.25U of Taq DNA polymerase and
1ml (500ng) of purified DNA. The amplification was performed on
a thermal cycler (STRATAGENE RoboCycler Gradient 96) accord-
ing to the following profile: an initial denaturation step at 98 ◦C
for 3min, after which taq polymerase was added, followed by 30
amplification cycles of 94 ◦C for 1min, 52 ◦C for 1min, and 72 ◦C for
2min, and a final extension step of 72 ◦C for 10min. The PCR prod-
uct was detected by agarose gel electrophoresis andwas visualized
by ultraviolet (UV) fluorescence after ethidium bromide staining.
The PCR products obtained were sent to the MilleGen Company
(Toulouse, France) for sequence determination. The same primers
as above and an automated sequencer were used for this purpose.
The sequences obtained were compared with sequences present
in the public sequence databases and with the EzTaxon-e server
(http://eztaxon-e.ezbiocloud.net/; Kim et al. 2012), a web-based
tool for the identification of prokaryotes based on 16S rRNA gene
sequences from type strains.
2.2.5. Phylogenetic analysis
Phylogenetic analyses were conducted using MEGA version 5
(Tamura et al. 2011). The 16S rRNA gene sequence of strain SA198
was aligned using the CLUSTALW program (Thompson et al. 1994)
against corresponding nucleotide sequences of representatives of
the Saccharothrix genus retrieved from GenBank. Phylogenetic tree
was inferred by the maximum-likelihood method (Felsenstein
1981)withKimura2-parameter (Kimura1980)model. Tree topolo-
gies were evaluated by bootstrap analysis (Felsenstein 1985) based
on 1000 resamplings.
2.3. Antimicrobial activity
The potential activity of the SA198 strain against various
microorganisms (bacteria, filamentous fungi andyeasts)wasevalu-
ated on ISP2medium by the streakmethod. Plates were inoculated
with strain culture by a single streak and incubated at 30 ◦C for 10
days. Later, target microorganisms were seeded in streaks perpen-
dicular to the actinomycete strain (a single streak for each at 90◦
to actinomycete strain). The antimicrobial activity was evaluated
by measuring the distance of inhibition between target microor-
ganisms and actinomycete colony margins, after incubation at
30 ◦C for 24h for bacteria and yeasts, and 36h for filamentous
fungi.
2.4. Time course of growth and antibiotic production
Fermentation was carried out in ISP2 broth medium for 10 days
in order to select the culture time favorable for antibiotic produc-
tion from strain SA198. The 500-ml Erlenmeyer flasks containing
100ml ofmediumwere inoculatedwith 3ml of a pre-culture broth
of strain SA198 prepared with the same medium and incubated at
30 ◦C for 2 days. The cultures were incubated on a rotary shaker
(250 rpm) at 30 ◦C for 10 days. Changes in pH, growth (dry weight
of mycelium), and antibiotic production were examined daily. The
antimicrobial activity in the culture broth was monitored by the
conventional agar diffusion assay (well technique) using Bacillus
subtilis, Aspergillus carbonarius and Mucor ramannianus. Each 10-
mm-diameter well was filled with 0.2ml of supernatant.
To purify the antibiotics, repeated fermentations were carried
out to obtain a total of 7.0 L of culture broth.
2.5. Extraction and purification of antibiotics
The culture broth was centrifuged to remove the biomass.
The cell-free supernatant was extracted with an equal volume of
dichloromethane. The organic extractwas concentrated to dryness.
The resulting dry extract was recovered in 1ml of methanol and
bioassayed against B. subtilis, A. carbonarius andM. ramaniannus.
Preparative chromatography with silica gel plates (Merck ART.
5735, Kiesselgel 60F 254) was used for the partial purification of
the antimicrobial products. The crude extract was dissolved in
methanol, spotted and developed with an ethyl acetate–methanol
mixture (100:15, v/v). The active spots were detected by bioau-
tography (Betina 1973) on silica gel plates seeded with B. subtilis,
A. carbonarius and M. ramaniannus. The active compounds were
also examined with the naked eye and visualized under UV at
254nm (absorbance) and 365nm (fluorescence), and by chemical
reagents.
The final purification of the semi-purified antibiotic compounds
was determined byWaters high-performance liquid chromatogra-
phy (HPLC) using a C18 (5mm) column (200mm×10mm, Waters
XBridge). A linear gradient of methanol–H2O (30–100% for 40min)
was used as the mobile phase. The elution rate was 2ml/min and
the detection was carried out at 220 and 261nm. Two peaks were
collected separately, concentratedand then testedagainstB. subtilis
andM. ramaniannus.
2.6. Spectroscopy and spectrometry of antibiotics
These analyses were made with the pure antimicrobial com-
pounds. The UV spectrum was determined with a Shimadzu
UV1605 spectrophotometer. The infrared (IR) spectrum was mea-
sured on a Shimadzu IR 470 using KBr tablets. The mass spectrum
was recorded on an LCQ ion-trap mass spectrometer (Finnigan
MAT, San Jose, CA) with nanospray ion electro-spray ionization
(ESI) source (positive and negative ion mode). The accurate mass
spectrometry (HREIMS) was carried out on a GCT Premier System.
Nuclear magnetic resonance (NMR) of the proton and carbon 13
was carried out with a Bruker Avance 500 spectrometer equipped
with a 5mm triple resonance inverse Z-gradient probe (TBI 1H, 31P,
BB). The NMR sample was prepared by dissolving 3mg of com-
pound A4 or A5 in 600ml of CD3OD. All chemical shifts for
1H and
13C were relative to TMS using 1H (residual) or 13C chemical shifts
of the solvent as a secondary standard. The temperature was set
at 298K. All the 1H and 13C signals were assigned on the basis
of chemical shifts, spin–spin coupling constants, splitting patterns
and signal intensities, and by using 1H–1H COSY45, 1H–13C HSQC
and 1H–13C HMBC experiments. Gradient-enhanced 1H COSY45
included 36 scans per increment. 1H–13C correlation spectra using
a gradient-enhanced HSQC sequence (delay was optimized for
1JCH of 145Hz) were obtained with 120 scans per increment.
A gradient-enhanced HMBC experiment was performed allowing
62.5ms for long-range coupling evolution (240 scans were accu-
mulated). Typically, 2048 t2 data points were collected for 256 t1
increments.
2.7. Minimum inhibitory concentration (MIC)
The minimum inhibitory concentrations were quantified by
incorporating known concentrations of antibiotic into solid growth
medium using a conventional agar dilution method (Oki et al.
1990). Inocula of six bacteria (B. subtilis, Enterococcus faecalis,
Escherichia coli, Klebsiella pneumoniae, Listeria monocytogenes and
Pseudomonas aeruginosa), six fungi (Ascochyta fabae, A. carbonarius,
Fusarium culmorum, Fusarium equiseti, M. ramaniannus and Peni-
cillium expansum) and two yeasts (Saccharomyces cerevisiae and
Candida albicans) were inoculated onto Mueller Hinton medium
for bacteria and Sabouraud medium for fungi, containing different
concentrations of active products (0.5, 1, 2, 5, 10, 20, 30, 50, 75 and
100mgml−1). After a growth period of 24–48h at 37 ◦C for bacteria
and 48–72h at 28 ◦C for fungi, the plateswere examined for growth
Fig. 1. Scanning electron micrography of spore chains of strain SA198 grown on
ISP2 for 10 days at 30 ◦C. Bar, 5mm.
and the lowest antibiotic concentration that inhibited the growth
of each organism was determined. Mueller Hinton and Sabouraud
media, without active products and inoculated with target orga-
nisms, was used as a control treatment.
Table 1
Physiological characteristics of the strain SA198.
Tests Result Tests Result
Hydrolysis of Trehalose −
Adenine − Xylose −
Arbutin −
Casein + Utilization of amino acids
Esculin + Alanine +
Gelatine + Proline +
Guanine − Serine −
Hypoxanthine +
Starch − Production of melanoid
Testosterone − Pigments on ISP7 medium +
Tween 80 +
Tyrosine + Decarboxylation of sodium salts
Xanthine − Acetate +
Benzoate −
Utilization of glucides and
derivates
Butyrate −
Citrate −
Adonitol − Oxalate −
Arabinose − Propionate +
Cellobiose + Pyruvate +
Fructose + Succinate +
Galactose − Tartrate −
Glucose +
Glycerol − Nitrate reduction −
Inositol −
Lactose − Growth at
Maltose − 37 ◦C +
Mannitol − 45 ◦C −
Mannose − pH 5.0 −
Melezitose − pH 9.0 +
Melibiose −
Raffinose − Growth in the presence of
Rhamnose − antibiotics
Ribose + Chloramphenicol (30mgml−1) −
Salicin − Erythromycin (15mgml−1) −
Sorbitol − Novobiocin (5mgml−1) +
Sucrose +
+, positive test; −, negative test.
3. Results
3.1. Taxonomy
The strain SA198 showed very good growth with production
of yellowish white aerial mycelium (MA) on ISP2, ISP3, ISP4 and
Bennett media, and moderate to good growth on TSA and nutrient
agar media without MA, after 14 days of incubation at 30 ◦C. The
color of substrate mycelium (MS) was strong reddish brown on
ISP2, strong yellowish brown on ISP3 and Bennett, light brown on
ISP4, light yellow on TSA and light yellowish brown on nutrient
agar.
Micromorphological characteristics of strain SA198 were con-
sistentwith those of the genus Saccharothrix. Its aerial hyphaewere
straight to irregularly curved, often with a zigzag shape. At the
maturation state, these hyphae fragmented irregularly into long
non-motile spore chains (Fig. 1). The MS was fragmented into rod-
shaped and coccoid elements.
Strain SA198 contained meso-diaminopimelic acid but not
glycine. Whole-cell hydrolysates contained galactose, rhamnose,
ribose and traces of mannose, which are typical of cell-wall
type IIIE (Stackebrandt et al. 1994). Diagnostic phospholipids
detected were phosphatidylethanolamine and phosphatidylhy-
droxyethanolmine, corresponding to type PII phospholipids
(Lechevalier et al. 1977).
The physiological properties of strain SA198 are shown in
Table 1. This strain produced melanoid pigments on the ISP7
medium but not on the ISP6 medium. It was able to degrade
casein esculin, gelatine, hypoxanthine, Tween 80 and tyrosine but
did not degrade adenine, arbutin, guanine, starch, testosterone, or
xanthine. Growth occurred at 37 ◦C, at pH 9.0 and in presence of
novobiocin (5mgml−1), but not at 45 ◦C, at pH 5.0 or in presence
of chloramphenicol (30mgml−1) or erythromycin (15mgml−1).
The strain SA198 was able to utilize alanine and proline as nitro-
gen sources, but not serine. Among the compounds tested, only
cellobiose, fructose, glucose, ribose, sucrose, acetate, propionate,
pyruvate and succinate were utilized as carbon sources.
The alignment of the 16S rRNA gene sequence (1368
nucleotides) of strain SA198, deposited inGenBankunder accession
number JN036396, with those of Saccharothrix reference species
available in the GenBank database can be seen in the maximum-
likelihood dendrogram (Fig. 2). The similarity level ranged from
97.2 to 98.8%, with Saccharothrix australiensis NRRL B-11239T
(Labeda et al. 1984) having the closest match.
Strain SA198 could also be distinguished from S. australiensis
by phenotypic properties, such as the color of aerial and substrate
mycelia, the production ofmelanoid pigments on ISP7medium, the
degradation of hypoxanthine and sucrose, the inability to use glyc-
erol, maltose, mannose, sorbitol, or trehalose, and the incapacity to
reduce nitrates or to grow at 45 ◦C.
Saccharothrix variisporea NRRL B-16296
T
/GQ917213
Saccharothrix sp. NRRL B-16133/AF114811
Saccharothrix mutabilis subsp. mutabilis DSM 43853
T
/X76966
Saccharothrix mutabilis subsp. capreolus DSM 40225
T
/X76965
Saccharothrix espanaensis NRRL 15764
T
/AF114807
Saccharothrix espanaensis An113/AB248288
Saccharothrix violaceirubra NBRC 102064
T
/AB284261
Saccharothrix sp. SA198/JN036396
Saccharothrix australiensis NRRL 11239
T
/AF114803
Saccharothrix algeriensis NRRL B-24137
T
/AY054972
Saccharothrix xinjiangensis NBRC 101911
T
/AB381939
Saccharothrix sp. SA103/FJ379335
Saccharothrix coeruleofusca NRRL B-16115
T
/AF114805
Saccharothrix syringae NRRL B-16468
T
/AF114812
Saccharothrix texasensis 3536/JN18184
Saccharothrix texasensis NRRL B-16107
T
/AF114815
Saccharothrix texasensis NRRL B-16134/AF114814
Saccharothrix hoggarensis DSM 45457
T
/HQ399564
Saccharothrix longispora DSM 43749/X76964
Saccharothrix longispora NRRL B-116116
T
/AF114809
Saccharothrix yanglingensis Hhs.015
T
/GQ284639
Saccharothrix sp. PAL54/JN225874
Umezawaea tangerina MK27-91F2
T
/AB020031
99
99
68
72
99
87
53
94
58
72
71
0.005
68
72
78
Fig. 2. Maximum-likelihood tree based on 16S rRNA gene sequence showing the relations between strain SA198 and type species of the genus Saccharothrix. The numbers at
the nodes indicate the levels of bootstrap support based onmaximum-likelihood analyses of 1000 resampled data sets (only values >50% are shown). Bar, 0.005 nt substitution
per nt position. Umezawaea tangerinaMK27-91F2T has been used as outgroup.
Table 2
Antimicrobial activity of the strain SA198 on ISP2 medium.
Test organisms Distance of inhibition (mm)
Gram-positive bacteria
Bacillus subtilis 20
Enterococcus faecalis 25
Listeria monocytogenes 09
Gram-negative bacteria
Escherichia coli 09
Klebsiella pneumoniae 02
Pseudomonas aeruginosa 08
Filamentous fungi
Ascochyta fabae 27
Aspergillus carbonarius 40
Fusarium culmorum 20
Fusarium equiseti 20
Mucor ramannianus 43
Penicillium expansum 45
Yeasts
Saccharomyces cerevisiae 00
Candida albicans 00
3.2. Antimicrobial activity
The strain SA198 showed broad-spectrum antimicrobial activ-
ity on ISP2 medium (Table 2). It was active against Gram-positive
and Gram-negative bacteria and filamentous fungi, but not against
yeasts. It showed strong to very strong activity against fungi such
as A. fabae, A. carbonarius, F. culmorum, F. equiseti and P. expansum,
and against bacteria such as B. subtilis and Enterococcus faecalis.
3.3. Time course of growth and antibiotic production
The kinetics of antibiotic production, growth and pHweremon-
itored in ISP2 broth cultures, as shown in Fig. 3. The activities were
detected on the first day of fermentation against B. subtilis and M.
ramannianus, andon the seconddayagainstA. carbonarius, reaching
a maximum the 8th day. The antifungal activity againstM. raman-
nianuswas stronger than that detected againstA. carbonarius and B.
subtilis. The antimicrobial activity was found to be correlated with
the cell growth, so the biomass increased from the first day to the
8th day, and then decreased after the 9th day. The pH increased
gradually to an alkaline state with a maximum (8.35) recorded on
the second day. It decreased after the third day and small variations
were recorded thereafter.
3.4. Isolation and purification of antibiotics
The cell-free supernatant of the 7.0 L shake culture was
extracted by dichloromethane. The yellow organic phase was con-
centrated to dryness. The TLC plate analysis showed the presence
of an active yellow spot designated A, detected by bioautography
at Rf =0.37, which exhibited antibacterial and antifungal activ-
ities. The preparative silica gel plates were then used to spot
dichloromethane crude extract in bands in order to collect an
appreciable quantity. The active bands were recovered and des-
orbed in methanol, concentrated to dryness and used for the final
purification by HPLC using a reverse-phase column.
The HPLC profile obtained showed two peaks with antibacte-
rial and antifungal activities, which were designated A4 (retention
time: RT, 18.50min) and A5 (RT, 20.7min). Each peakwas collected
separately and re-injected into the HPLC system until total purifi-
cation was achieved. The pure antibiotics had a strong yellowish
color.
Chromogenic reactions for A4 andA5 compoundswere negative
with FeCl3, ninhydrine and naphtoresorcinol–H2SO4.
Fig. 3. Time course of growth, pH and antimicrobial activity in ISP2medium against
Bacillus subtilis (), Aspergillus carbonarius () and Mucor ramannianus (N). Bars
indicate standard deviation of the mean.
3.5. Spectroscopy and spectrometry analyses of antibiotics
The UV–visible spectra in methanol (data not shown) exhib-
ited a maximal absorption at 262.5 and 343.7nm for A4 and
at 263.3 and 343.3nm for A5. The infrared spectra of A4 and
A5 molecules showed the presence of bands at 3323–3453 cm−1
(hydroxyl groups), 2850–2951 and 1434–1464 cm−1 (aliphatic
C H), 1685–1735 cm−1 (C O), 1517–1634 cm−1 (C C of aromatic
ring) and 1151–1156 cm−1 (C O). The ESI-MS spectra contained an
ion peak at m/z 505.55 [M−H]− for A4 and at m/z 519.75 [M−H]−
for A5, and their molecular formulas were determined by HRESI-
MS analysis as C29H30O8 [calcd. 506.1838, found 506.1819] and
C30H32O8 [calcd. 520.1995, found 520.1983] for A4 and A5 respec-
tively. Optical rotation of the two antibioticswere [a]D
21 +8 (c 0.05,
MeOH) for A4 and [a]D
21 +33.9 (c 0.07, MeOH) for A5.
The 1H and 13C chemical shifts of A4 and A5 compounds are
given in Table 3 and their structures can be seen in Figs. 4 and 5.
The 13C andHSQC spectra show29 carbon signals for compound
A4 and 30 carbon signals for molecule A5. From the 13C data, it was
possible to discern one ketone group (ıc 198.5), two enolic groups
(ıc 166.5), one carboxylate group (ıc 189.2) one hydroxyl group
(ıc 71.0), one epoxy group (ıc 52.5 and 56.9), 13 sp2-hybridized
carbons (ıc from 121.5 to 150.5), and five sp3-hybridized carbons
(ıc 20.8–31.4) for molecule A4, and six sp3-hybridized carbons
(ıc 10.7–38.8) for compound A5. The hydrogens of the hydroxyl
and enol groups were not observed due to rapid exchange with
MeOD. The 2D 1H–1H and 1H–13C experiments and, especially, the
Table 3
1H and 13C NMR data assignments of A4 and A5 compounds in CD3OD at 298K. See
Figs. 4 and 5 for numbering of hydrogen and carbon atoms.
1H and 13C number 1Hchemical shift, ppm 13Cchemical shift, ppm
A4 A5 A4 A5
1 3.62 3.62 52.5 52.5
2 3.69 3.70 56.9 56.9
3 − − 71.0 71.0
4 7.22 7.22 129.2 129.1
5 − − 128.1 128.1
6 − − 189.2 189.2
7 5.84 5.85 134.9 134.9
8 6.57 6.58 131.5 131.5
9 6.48 6.48 134.3 134.3
10 6.46 6.47 133.9 133.9
11 6.61 6.61 138.4 138.3
12 6.47 6.47 131.6 131.6
13 7.23 7.22 139.7 139.7
14 6.21 6.21 124.6 124.6
15–22 − − 166.5 166.5
16–21 − − 110.7 110.8
17–20 − − 198.5 198.5
18–19 2.36 2.36 30.4 30.3
23 6.18 6.17 121.5 121.4
24 7.21 7.22 142.9 142.9
25 6.24 6.25 125.6 126.9
26 6.15 6.06 150.5 149.5
27 2.45 2.21 31.4 38.8
28 1.08 1.07 20.8 18.6
29 1.08 1.42 20.8 29.00
30 − 0.91 − 10.7
long range 1H–13C couplings observed in the HMBC spectrum (see
Figs. 4 and 5) established the connectivity between all the groups
of molecules A4 and A5.
The structure of the A4 and A5 compounds was deter-
mined by NMR and mass spectrometry as respectively
4-hydroxy-4-{9-hydroxy-9-[2-(1-hydroxy-6-methyl-hepta-
2,4-dienylidene)-3,6-dioxo-cyclohexylidene]-nona-1,3,5,7-
tetraenyl}-6-oxa-bicyclo[3.1.0]hex-2-ene-2-carboxylic acid
and 4-hydroxy-4-{9-hydroxy-9-[2-(1-hydroxy-6-methyl-octa-
2,4-dienylidene)-3,6-dioxo-cyclohexylidene]-nona-1,3,5,7-
tetraenyl}-6-oxa-bicyclo[3.1.0]hex-2-ene-2-carboxylic acid.
Fig. 4. Structure of antibiotic A4 (a) and HMBC and COSY correlations (b).
Fig. 5. Structure of antibiotic A5 (a) and HMBC and COSY correlations (b).
Table 4
Minimum inhibitory concentrations (MIC) of new antibiotics A4 and A5 produced
by SA198 strain.
Test organism Antibiotics (mgml−1)
A4 A5
Bacillus subtilis 20 10
Enterococcus faecalis 10 10
Listeria monocytogenes 30 30
Escherichia coli 20 30
Klebsiella pneumoniae 50 50
Pseudomonas aeruginosa 30 30
Ascochyta fabae 20 10
Aspergillus carbonarius 10 02
Fusarium culmorum 40 20
F. equiseti 30 30
Mucor ramannianus 05 01
Penicillium expansum 02 02
Saccharomyces cerevisiae >100 >100
Candida albicans >100 >100
3.6. Minimum inhibitory concentration
The antimicrobial activity of compounds A4 and A5 is shown
in Table 4. A4 and A5 showed high activity against fungi such
as M. ramannianus (MIC: 5–1mgml−1), A. carbonarius (MIC:
10–2mgml−1) and P. expansum (MIC: 2–2mgml−1). Moderate
activity was also recorded against other filamentous fungi such as
A. fabae, F. culmorum and F. equiseti (MIC: 40–10mgml−1) as well
as Gram-negative bacteria (E. coli, K. pneumoniae and P. aeruginosa)
and Gram-positive bacteria (B. subtilis, E. faecalis and L. monocyto-
genes). However, the two yeast strains (C. albicans and S. cerevisiae)
have shown resistance (MIC: >100). The activity of A5 was more
potent than that of A4.
4. Discussion
On the basis of the morphological and chemical characteristics
described above, strain SA198 was classified in the genus Saccha-
rothrix (Labeda et al. 1984). Comparison with the Saccharothrix
species showed differences in the cultural characteristics and in
the physiological properties. The 16S rRNA gene sequence of strain
SA198was comparedwith those of other Saccharothrix species. The
similarity level ranged from 97.2 to 98.8%, S. australiensis (Labeda
et al. 1984) being the most closely related species. However, it is
clear from phylogenetic analysis that strain SA198 represents a
distinct phyletic line suggesting a new genomic species.
Our results showed that the antifungal activity was stronger
than the antibacterial one. The same observationswere announced
by Igarashi et al. (1997). These authors reported that the formam-
icinproducedbya strainof Saccharothrix sp. exhibitedbroad, strong
antifungal activity against phytopathogenic fungi and moderate
antibacterial activities against Gram-positive bacteria. Although
the activity of Saccharothrix species against Gram-positive bacte-
ria has been widely published (Takeuchi et al. 1992; Sabaou et al.
1998; Wang et al. 2001; Zitouni et al. 2005), its activity against
Gram-negative bacteria and fungi has been reported only rarely
(Suzuki et al. 1991; Kinochita et al. 1999).
The two compounds purified by HPLC showed antibacterial and
antifungal activity. Compound A5 was more potent than A4.
It is very interesting to note that the activity of the two
compounds is strong to moderate against filamentous fungi, but
without any activity against yeasts. Indeed, the work of Andriole
(1999) and Lass-Flörl et al. (2008) on many antifungal compounds
tested against a very large number of strains of yeasts and filamen-
tous fungi showed activity directed against these two groups of
microorganisms, which is also the case in almost all works cited in
the literature. In contrast, the studies showing activity against fila-
mentous fungi, with no activity against yeasts, are very rare (Hosoe
et al. 2004) or almost non-existent.
The data relative to chemical revelations and to the infrared
spectrum suggested that our antibiotics did not contain sugar, free
amine or phenol.
On the basis of NMR and HRESI-MS analysis, the molecular for-
mulas were determined as C29H30O8 for A4 and C30H32O8 for A5.
No resemblance was noted when the structures of compounds A4
and A5 were compared with those reported in the literature such
as databases www.sciencefinder.com and www.chemspider.com,
and also antibiotics described in dictionary of antibiotics and
related substances (Bycroft 1988), in dictionary of natural prod-
ucts (Buckingham 1997), and in the review of bioactive microbial
metabolites (Berdy 2005).
Saccharothrix species have been reported to produce antibiotics
belonging to the aminoglycoside and benzoquinone (Takahashi
et al. 1986), glycopeptide (Takeuchi et al. 1992), carboxylic nucleo-
side (Bush et al. 1993), dithiolopyrrolone (Lamari et al. 2002),
heptadecaglycoside (Singh et al. 2000), anthracyclin (Zitouni
et al. 2004a), macrolide (Murakami et al. 2009) and angucycline
(Kalinovskaya et al. 2010) families. No species of Saccharothrix is
known to produce antibiotics close to compounds A4 and A5.
In conclusion, the results of this study show that the strain
SA198 is different from known species of Saccharothrix, and pro-
duced new antimicrobial compounds.
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